05/31/17 11:07 AM EDT

FLASHBACK: Hedgeye Says Buy Exact Sciences | $EXAS

Takeaway: Shares of Exact Sciences are up +100% since our Healthcare team made their buy recommendation.

Shares of Exact Sciences (one of our healthcare team's favorite longs) have surged over 10% today. The stock soared after UnitedHealth Group said it plans to cover the company's colon cancer test starting on July 1. EXAS was targeted by short-seller Citron Research earlier this month -- one of the short-seller's allegations was that UnitedHealth Group wouldn't ever cover the test.

Here's our response to Citron Research earlier this month.

Here's our Sector Head Tom Tobin discussing our long call back in January. The stock is up 100% since then.

FLASHBACK: Hedgeye Says Buy Exact Sciences | $EXAS

EVENT | Energy Black Book (4/2)

The Pitch: 6 Analysts. 6 Stock Ideas. 60 Minutes

The Pitch: 6 Analysts. 6 Stock Ideas. 60 Minutes

FLASHBACK | 2 Retail Short Calls “Don't Have a Snot’s Worth of Chance” $ADDYY $AS

FLASHBACK | "Spectacular Value Destruction": Industrials Short Call $PLUG Down -50% in 2024

What 80-90% of Investors Don't Understand About DraftKings' Drawdown | $DKNG

WEBCAST | Rooms Where It Happened: Lessons from a Life in Government

Cartoon of the Day: Loose Lips Sink Ships

TERM OF THE DAY: Convexity

CHART OF THE DAY: Ride Your Winners

[FREE ACCESS] HedgAI Signals: 4/10/2024 (Long 30yr, HYG)

Cartoon of the Day: Low IQ

ICYMI | Hedgeye Investing Summit: Nancy Davis

ICYMI | Hedgeye Investing Summit: Dan Rasmussen

Market Situation Report: Soft Landing Dreams Fading

CHART OF THE DAY: How Much For A Burger?

Sign up for free: Hedgeye's Market Brief